Background and objectives:Various devices are used to study the unique electrical properties of acupuncture points(APs),with Voll’s electropuncture diagnostics(EAV)occupying a prominent role.The technical design of E...Background and objectives:Various devices are used to study the unique electrical properties of acupuncture points(APs),with Voll’s electropuncture diagnostics(EAV)occupying a prominent role.The technical design of EAV allows for the testing of drugs to determine their individual selection and dosages.However,the physiological basis of this phenomenon remains unclear.This study investigated the feasibility of evaluating the electrodermal activity of APs to determine the daily dose of ribavirin using electroacupuncture according to the Voll diagnostic system in patients with long COVID.Methods:This blind,randomized,placebo-controlled trial included 101 patients(aged 16 to 50)who met the definition of long COVID and were examined using an EAV testing system that measures the electrodermal activity of APs.Ribavirin was tested at the APs with established decreased electrical impedance readings to determine the daily doses.Fifty-two participants were randomized to the experimental group,and forty-nine to the placebo group.These patients were considered for data analysis.Results:The results of this study demonstrated the feasibility of using EAV to identify APs with decreased levels of electrodermal activity,followed by medicament testing(MT)of different ribavirin doses to restore the electrodermal activity at these points.Conclusions:The results indicated that the tested doses of ribavirin in patients with long COVID correlate with electrodermal activity at certain APs along specific meridians.Higher doses of the drug were associated with lower electrodermal activity readings during MT using the EAV diagnostic system.However,further clinical and instrumental studies are needed to evaluate the clinical application of MT in the assessment of long COVID.展开更多
文摘Background and objectives:Various devices are used to study the unique electrical properties of acupuncture points(APs),with Voll’s electropuncture diagnostics(EAV)occupying a prominent role.The technical design of EAV allows for the testing of drugs to determine their individual selection and dosages.However,the physiological basis of this phenomenon remains unclear.This study investigated the feasibility of evaluating the electrodermal activity of APs to determine the daily dose of ribavirin using electroacupuncture according to the Voll diagnostic system in patients with long COVID.Methods:This blind,randomized,placebo-controlled trial included 101 patients(aged 16 to 50)who met the definition of long COVID and were examined using an EAV testing system that measures the electrodermal activity of APs.Ribavirin was tested at the APs with established decreased electrical impedance readings to determine the daily doses.Fifty-two participants were randomized to the experimental group,and forty-nine to the placebo group.These patients were considered for data analysis.Results:The results of this study demonstrated the feasibility of using EAV to identify APs with decreased levels of electrodermal activity,followed by medicament testing(MT)of different ribavirin doses to restore the electrodermal activity at these points.Conclusions:The results indicated that the tested doses of ribavirin in patients with long COVID correlate with electrodermal activity at certain APs along specific meridians.Higher doses of the drug were associated with lower electrodermal activity readings during MT using the EAV diagnostic system.However,further clinical and instrumental studies are needed to evaluate the clinical application of MT in the assessment of long COVID.
